Chronic kidney disease as a risk factor for incident gout among men and women: Retrospective cohort study using data from the Framingham Heart Study

BMJ Open

Volumn 5, Issue 4, 2015, Pages

  Wang, Weiqi ^a   Bhole, Vidula Manish ^b   Krishnan, Eswar ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Epi Solutions Consultancy Services   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GOUT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; CHRONIC KIDNEY FAILURE; COMPLICATION; INCIDENCE; MASSACHUSETTS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

ADULT; FEMALE; GOUT; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84929309144     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006843     Document Type: Article

References (28)

1. Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000;11:974-9.
2. Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the United States. J Rheumatol 2008;35:498-501.
3. Krishnan E. Reduced glomerular function and prevalence of gout: NHANES 2009-10. PLoS ONE 2012;7:e50046.
4. Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008;40:437-42.
5. Saag KG, Mikuls TR. Recent advances in the epidemiology of gout. Curr Rheumatol Rep 2005;7:235-41.
6. Sorensen LB, Levinson DJ. Origin and extrarenal elimination of uric acid in man. Nephron 1975;14:7-20.
7. Rieselbach RE, Sorensen LB, Shelp WD, et al. Diminished renal urate secretion per nephron as a basis for primary gout. Ann Intern Med 1970;73:359-66.
8. Krishnan E. Chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study. Arthritis Rheum 2013;65:3271-8.
9. Talbott JH, Terplan KL. The kidney in gout. Medicine 1960;39:405-67.
10. Sorensen LF. Gout secondary to chronic renal disease: studies on urate metabolism. Ann Rheum Dis 1980;39:424-30.
11. Krishnan E, Akhras KS, Sharma H, et al. Serum urate and incidence of kidney disease among veterans with gout. J Rheumatol 2013;40:1166-72.
12. Fuldeore MJ, Riedel AA, Zarotsky V, et al. Chronic kidney disease in gout in a managed care setting. BMC Nephrol 2011;12:36.
13. Avram Z, Krishnan E. Hyperuricaemia - where nephrology meets rheumatology. Rheumatology 2008;47:960-4.
14. Juraschek SP, Kovell LC, Miller ER III, et al. Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010. Semin Arthritis Rheum 2013;42:551-61.
15. Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007;49:298-303.
16. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951;41:279-81.
17. Abbott RD, Brand FN, Kannel WB, et al. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988;41:237-42.
18. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.
19. Parikh NI, Hwang SJ, Larson MG, et al. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2008;102:47-53.
20. Weiner DE, Tighiouart H, Elsayed EF, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 2007;50:217-24.
21. Fox CS, Larson MG, Leip EP, et al. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care 2005;28:2436-40.
22. [No authors listed]. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
23. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009;119:1728-35.
24. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol 1996;25:1107-16.
25. Teng GG, Ang LW, Saag KG, et al. Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Ann Rheum Dis 2012;71:924-8.
26. Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 2000;10:403-9.
27. Stamp L, Ha L, Searle M, et al. Gout in renal transplant recipients. Nephrology 2006;11:367-71.
28. Edwards NL. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med 2008;75(Suppl 5):S13-16.